Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Docosahexaenoic Acid Reverses the Promoting Effects of Breast Tumor Cell-Derived Exosomes on Endothelial Cell Migration and Angiogenesis Publisher Pubmed



Ghaffarimakhmalbaf P1 ; Sayyad M1 ; Pakravan K2 ; Razmara E3 ; Bitaraf A2 ; Bakhshinejad B2 ; Goudarzi P1 ; Yousefi H4 ; Pournaghshband M1 ; Nemati F5 ; Fahimi H1 ; Rohollah F1 ; Hasanzad M6 ; Hashemi M1 Show All Authors
Authors
  1. Ghaffarimakhmalbaf P1
  2. Sayyad M1
  3. Pakravan K2
  4. Razmara E3
  5. Bitaraf A2
  6. Bakhshinejad B2
  7. Goudarzi P1
  8. Yousefi H4
  9. Pournaghshband M1
  10. Nemati F5
  11. Fahimi H1
  12. Rohollah F1
  13. Hasanzad M6
  14. Hashemi M1
  15. Mousavi SH7
  16. Babashah S2
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  2. 2. Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  3. 3. Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  4. 4. Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, New Orleans, United States
  5. 5. Department of Biotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  6. 6. Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  7. 7. Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Source: Life Sciences Published:2021


Abstract

Aim: As a natural compound, docosahexaenoic acid (DHA) exerts anti-cancer and anti-angiogenesis functions through exosomes; however, little is known about the molecular mechanisms. Main methods: Breast cancer (BC) cells were treated with DHA (50 μM) and then tumor cell-derived exosomes (TDEs) were collected and characterized by electron microscopy, dynamic light scattering, and western blot analyses. By the time the cells were treated with DHA, RT-qPCR was used to investigate the expression of vascular endothelial growth factor (VEGF) and the selected pro- and anti-angiogenic microRNAs (miRNAs). The quantification of secreted VEGF protein was measured by enzyme-linked immunosorbent assay (ELISA). The effects of TDEs on endothelial cell angiogenesis were explored by transwell cell migration and in vitro vascular tube formation assays. Key findings: DHA treatment caused a significant and time-dependent decrease in the expression and secretion of VEGF in/from BC cells. This also increased expression of anti-angiogenic miRNAs (i.e. miR-34a, miR-125b, miR-221, and miR-222) while decreased levels of pro-angiogenic miRNAs (i.e. miR-9, miR-17-5p, miR-19a, miR-126, miR-130a, miR-132, miR-296, and miR-378) in exosomes derived from DHA-treated BC cells, TDE (DHA+). While treatment with exosomes (100 μg/ml) obtained from untreated BC cells, TDE (DHA−), enhanced the expression of VEGF-A in human umbilical vein endothelial cells (HUVECs), incubation with DHA or TDE (DHA+) led to the significant decrease of VEGF-A transcript level in these cells. We indicated that the incubation with TDE (DHA+) could significantly decrease endothelial cell proliferation and migration and also the length and number of tubes made by HUVECs in comparison with endothelial cells incubated with exosomes obtained from untreated BC cells. Significance: DHA alters angiogenesis by shifting the up-regulation of exosomal miRNA contents from pro-angiogenic to anti-angiogenic, resulting in the inhibition of endothelial cell angiogenesis. These data can help to figure out DHA's anti-cancer function, maybe its use in cancer therapy. © 2020 Elsevier Inc.